Valley Heart & Vascular Institute - Clinical Trials
Share |

Valve Trials

MEDSTAR TAVR

“Feasibilty of Transcatheter Aortic Valve Replacement in Low-Risk Patients with Symptomatic, Severe Aortic Stenosis.”

Study Objective: To assess the safety and feasibility of Transcatheter Aortic Valve Replacement (TAVR) with commercially available bioprostheses in patients with severe, symptomatic aortic stenosis (AS) who are low-risk (STS score ≤3%) for surgical aortic valve replacement (SAVR).

Eligibility: Disease of aortic valve.

Principal Investigator: John Goncalves, MD


 
Copyright © 2018 Valley Health System. All rights reserved.